Wound closure and wound management: A new therapeutic molecular target.
Wound closure and infection control are the primary goal of wound management. A variety of disinfectants and antimicrobial agents are widely available today and routinely achieve infection control. On the contrary, wound closure still remains a challenging goal. Cell adhesion, migration and contraction play significant roles in creating contractile force of patent wound margins and in contributing to wound closure. Modulations of these cellular behaviors have been investigated in the context of wound contraction; however, therapeutic strategy to achieve wound closure has not been established. Recently, we have reported that a previously unknown cytoskeleton molecule, wound inducible transcript-3.0 (wit3.0) also known as fibroblast growth factor receptor 1 oncogene partner 2 (FGFR1OP2), can significantly modulate fibroblast-driven wound closure in vitro and in vivo. The dynamic role of cytoskeleton in different experimental models may provide a novel platform for designing the therapeutic target of wound management.
Lin
Audrey
A
The Weintraub Center for Reconstructive Biotechnology, UCLA School of Dentistry, Los Angeles, CA, USA.
Hokugo
Akishige
A
Nishimura
Ichiro
I
D000199:Actins / Q000378:metabolism; D000818:Animals; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D004331:Drosophila melanogaster / Q000196:embryology; D004625:Embryo, Nonmammalian / Q000378:metabolism / Q000473:pathology; D005333:Fetus / Q000378:metabolism / Q000473:pathology; D006801:Humans; D009061:Mouth Mucosa / Q000378:metabolism / Q000473:pathology; D051381:Rats; D014945:Wound Healing / Q000502:physiology*
D000199:Actins; D003598:Cytoskeletal Proteins
Ann Surg. 1934 Dec;100(6):1159-76
17856427
N Engl J Med. 1999 Sep 2;341(10):738-46
10471461
Crit Rev Oral Biol Med. 1996;7(4):300-18
8986393
J Cell Biol. 1996 Nov;135(4):1097-107
8922389
Kobe J Med Sci. 2009 Jun 05;55(1):E5-E15
19628973
Cell Biol Int. 1995 May;19(5):471-6
7640660
Am J Pathol. 2010 Jan;176(1):108-21
19959814
FASEB J. 2000 Nov;14(14):2213-20
11053242
Cell. 2009 Jun 26;137(7):1331-42
19563762
Diabetes. 2001 Sep;50(9):2100-4
11522677
Science. 2008 Sep 19;321(5896):1683-6
18802000
J Surg Res. 1991 Apr;50(4):375-85
2020189
Am J Pathol. 2000 Aug;157(2):423-33
10934147
J Exp Med. 1972 Apr 1;135(4):719-34
4336123
Acta Otolaryngol. 1995 Mar;115(2):348-51
7610839
J Dent Res. 1998 Sep;77(9):1717-29
9759669
Front Biosci. 2003 Sep 01;8:s1240-8
12957846
Cell Motil Cytoskeleton. 2007 Apr;64(4):248-57
17183543
Genes Chromosomes Cancer. 2004 May;40(1):78-83
15034873
Eur J Oral Sci. 2002 Apr;110(2):130-6
12013556
Nature. 1992 Nov 12;360(6400):179-83
1436096
Am J Physiol. 1996 Jan;270(1 Pt 1):G191-202
8772518
Clin Oral Investig. 2002 Mar;6(1):39-50
11996162
Clin Med Res. 2004 May;2(2):115-8
15931344
Dev Biol. 1995 Jul;170(1):102-14
7601301
Curr Biol. 2005 Dec 20;15(24):2208-21
16360683
Adv Skin Wound Care. 2007 Jan;20(1):39-53; quiz 53-5
17195786
Br Med J. 1971 Jan 9;1(5740):67-72
5539177
Br J Dermatol. 2001 Feb;144(2):229-37
11251552
Pathol Res Pract. 1994 Oct;190(9-10):851-3
7899134
J Cell Sci. 1991 Jul;99 ( Pt 3):583-6
1719005
J Dent Res. 2002 Apr;81(4):229-35
12097305
J Biol Chem. 2003 Dec 19;278(51):51527-34
14527947
Int J Biochem Cell Biol. 1997 Jan;29(1):63-78
9076942
Science. 1997 Apr 4;276(5309):75-81
9082989
Nat Cell Biol. 2002 Nov;4(11):907-12
12402048
Philos Trans R Soc Lond B Biol Sci. 2004 May 29;359(1445):839-50
15293811
J Biol Chem. 2006 Dec 29;281(52):40193-200
17090535
Eur J Biochem. 1981 Jan;113(3):595-603
6783401